SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.91%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$497M
AUM Growth
+$497M
(+66%)
Cap. Flow
-$12.7M
Cap. Flow
% of AUM
-2.55%
Top 10 Holdings %
Top 10 Hldgs %
59.18%
Holding
270
New
59
Increased
53
Reduced
43
Closed
46
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$22.4M |
| 2 |
Amgen
AMGN
|
$21.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$14.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
$9.88M |
| 5 |
Biogen
BIIB
|
$9.65M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$33.1M |
| 2 |
Plus Therapeutics
PSTV
|
$19.2M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$9.8M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
$7.26M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$6.48M |
Sector Composition
| 1 | Healthcare | 48.01% |
| 2 | Consumer Staples | 0.23% |
| 3 | Technology | 0.19% |
| 4 | Industrials | 0.18% |
| 5 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OTIC
101
DELISTED
Otonomy, Inc.
OTIC
| $746K | 0.04% |
+50,000
| New | +$746K |
|
102
Benitec Biopharma
BNTC
$365M
| $739K | 0.04% |
422,101
-175,014
| -29% | -$307K |
|
103
ProQR Therapeutics
PRQR
$256M
| $732K | 0.04% |
149,934
+110,063
| +276% | +$537K |
|
104
vTv Therapeutics
VTVT
$49.4M
| $721K | 0.04% |
139,747
| – | – |
|
|
ANTH
105
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $720K | 0.04% |
+198,918
| New | +$720K |
|
|
BLCM
106
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $720K | 0.04% |
+77,020
| New | +$720K |
|
|
ATRS
107
DELISTED
Antares Pharma, Inc.
ATRS
| $675K | 0.03% |
775,212
+16,494
| +2% | +$14.4K |
|
108
Natera
NTRA
$23B
| $659K | 0.03% |
69,272
-17,351
| -20% | -$165K |
|
109
Soleno Therapeutics
SLNO
$3.56B
| $637K | 0.03% |
+530,524
| New | +$637K |
|
110
Cyclacel Pharmaceuticals
CYCC
$17.2M
| $628K | 0.03% |
1,632,259
+121,453
| +8% | – |
|
|
SCPX
111
DELISTED
Scorpius Holdings, Inc.
SCPX
| $626K | 0.03% |
+880,036
| New | +$626K |
|
|
CBMXW
112
DELISTED
CombiMatrix Corporation Warrant
CBMXW
| $610K | 0.03% |
+911,041
| New | +$610K |
|
|
AKTX
113
Akari Therapeutics
AKTX
$21.4M
| $606K | 0.03% |
+40,705
| New | +$606K |
|
114
Halozyme
HALO
$8.75B
| $568K | 0.03% |
+60,000
| New | +$568K |
|
115
Strata Skin Sciences
SSKN
$7.84M
| $542K | 0.03% |
573,077
-338,704
| -37% | -$320K |
|
|
BPMC
116
DELISTED
Blueprint Medicines
BPMC
| $535K | 0.03% |
+29,624
| New | +$535K |
|
|
SCON
117
DELISTED
Superconductor Technologies Inc.
SCON
| $523K | 0.03% |
2,734,500
+384,508
| +16% | +$73.4K |
|
118
Capricor Therapeutics
CAPR
$287M
| $513K | 0.03% |
202,083
+16,419
| +9% | +$41.7K |
|
119
Alkermes
ALKS
$4.95B
| $513K | 0.03% |
15,000
-116,671
| -89% | -$3.99M |
|
120
Cidara Therapeutics
CDTX
$1.61B
| $512K | 0.03% |
+40,277
| New | +$512K |
|
121
Amicus Therapeutics
FOLD
$2.42B
| $501K | 0.03% |
59,324
+33,663
| +131% | +$284K |
|
122
Insmed
INSM
$30.3B
| $454K | 0.02% |
+35,867
| New | +$454K |
|
123
Senseonics Holdings
SENS
$368M
| $440K | 0.02% |
+153,900
| New | +$440K |
|
|
KOOL
124
North Shore Equity Rotation ETF
KOOL
$53.5M
| $432K | 0.02% |
+111,094
| New | +$432K |
|
|
FLXN
125
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $426K | 0.02% |
+46,355
| New | +$426K |
|